Atlas Trials

Safety Study of GSK Biologicals' Rotavirus Vaccine (Rotarix®) Administered to Children Aged <1 Year in the United States

Clinical trial NCT00875641 · COMPLETED

Trial details

NCT number
NCT00875641
Sponsor
GlaxoSmithKline
Status
COMPLETED
Study type
OBSERVATIONAL
Infections, Rotavirus
Start date
2009-04-20
Primary completion
2016-11-04
Enrollment
390659

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.